Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

October 01, 2006 (Vol. 26, No. 17)

BioMarket Trends

Guidance for Determining the Utility of Biodisposables in Biomanufacturing

  • The value of the primary and secondary U.S. biomanufacturing market in 2006 is estimated to be approximately $50 billion with a healthy growth rate almost approaching double digits due to the escalating number of biotech drugs in the pipeline and skyrocketing sales of approved high-value, life-saving biopharmaceuticals. D&MD’s ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.